Collins James J. 4
4 · Fulcrum Therapeutics, Inc. · Filed Jul 18, 2019
Insider Transaction Report
Form 4
Collins James J.
Director
Transactions
- Award
Stock Option (right to buy)
2019-07-18+5,714→ 5,714 totalExercise: $16.00Exp: 2029-07-17→ Common Stock (5,714 underlying)
Footnotes (1)
- [F1]The option was granted on July 18, 2019. The shares underlying the option are scheduled to vest on July 18, 2020 or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date.